1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride, 95.0%, 100mg

Methyl 2-methyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 97%, 100mg

(4-(3-Fluorophenoxy)phenyl)boronic acid, 95.0%, 1g

N-Ethyl-p-menthane-3-carboxamide, 95.0%, 500g

GC capillary column ROTI®Cap-624, 30 m, 0.32 mm, 1.80 µm, 1 Piece(s)

5-(TRIFLUOROMETHYL)CYCLOHEXANE-1,3-DIONE, 95.0%, 500mg

(S)-4-Methoxy-3-methyl-4-oxobutanoic acid, 97%, 250mg

2-Fluoro-6-(trifluoromethyl)pyridine-3-carboxylic acid, 97%, 5g

5-FLUOROAZEPAN-4-OL HCL, 95.0%, 1g

2-(5-FLUOROPYRIDIN-3-YL)ACETONITRILE, 95.0%, 500mg

2-methyl-3-[(tetrahydro-2-furanylcarbonyl)amino]benzoic acid, 95.0%, 5g

(S)-TERT-BUTYL 2-METHYL-3-OXOPIPERAZINE-1-CARBOXYLATE, 95.0%, 10g

(6-ETHYLSULFANYL-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg